Vietnam Institute Seeks Human Trials On Bird-Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
A health institute has applied to Vietnam's Health Ministry to be allowed to begin human trials on an avian-influenza vaccine it has developed. The Nha Trang Institute of Vaccines and Medical Biological said it is ready for human trials following successful tests of the vaccine on animals. Backed by World Health Organization funds, the institute is building a plant capable of producing as many as a million doses of vaccine a year. A separate bird-flu trial has been testing a vaccine on Vietnamese military volunteers. (Click here for more
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.